Department of Pharmacology

January 29, 2024

Expanded space boosts cutting-edge research in infectious diseases and immunology

The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.

January 18, 2024

Beloved VUMC colleague and acclaimed scientist David Robertson mourned

David Robertson, MD, a beloved leader and mentor, and a pioneer in the clinical research of blood pressure disorders at Vanderbilt University Medical Center, died Jan. 12 at his home in Nashville. He was 76.

January 16, 2024

‘Molecular Muse’ exhibit features Artist-in-Residence program’s science-inspired art

The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool.

November 14, 2023

Future of AI in medicine is bright, but rigorous validation needed

Artificial intelligence has the potential to transform the practice of medicine but, like any other new tool or method, it needs to be rigorously validated before it is widely applied, cautions Vanderbilt’s Dan Roden, MD.

September 15, 2023

Four named Master Innovators at Vanderbilt

Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher as Master Innovators at Vanderbilt.

August 17, 2023

Grant aids drug discovery for autism, schizophrenia

Federal grant to help Vanderbilt researchers will pave the way for potential treatments for schizophrenia and autism spectrum disorder